Vespa crabro chromosome 24, iyVesCrab1.2, whole genome shotgun sequence.
Eukaryota; Metazoa; Ecdysozoa; Arthropoda; Hexapoda; Insecta; Pterygota; Neoptera; Endopterygota; Hymenoptera; Apocrita; Aculeata; Vespoidea; Vespidae; Vespinae; Vespa.
REFSEQ INFORMATION: The reference sequence is identical to\nOU342423.1.\nAssembly name: iyVesCrab1.2\nThe genomic sequence for this RefSeq record is from the\nwhole-genome assembly released by the WELLCOME SANGER INSTITUTE on\n2022/02/09. The original whole-genome shotgun project has the\naccession CAJUUB000000000.2.\n\n##Genome-Annotation-Data-START##\nAnnotation Provider :: NCBI\nAnnotation Status :: Full annotation\nAnnotation Name :: Vespa crabro Annotation Release 100\nAnnotation Version :: 100\nAnnotation Pipeline :: NCBI eukaryotic genome annotation\n pipeline\nAnnotation Software Version :: 9.0\nAnnotation Method :: Best-placed RefSeq; Gnomon\nFeatures Annotated :: Gene; mRNA; CDS; ncRNA\n##Genome-Annotation-Data-END##
Derived by automated computational analysis using gene prediction method: Gnomon.
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: deleted 1 base in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 72% coverage of the annotated genomic feature by RNAseq alignments
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: deleted 1 base in 1 codon; substituted 1 base at 1 genomic stop codon; Derived by automated computational analysis using gene prediction method: Gnomon.
LOW QUALITY PROTEIN: sarcoplasmic calcium-binding protein
ubiquitin recognition factor in ER-associated degradation protein 1, transcript variant X2
COORDINATES: polyA evidence [ECO:0006239]
ubiquitin recognition factor in ER-associated degradation protein 1, transcript variant X1
ubiquitin recognition factor in ER-associated degradation protein 1 isoform X2
ubiquitin fusion degradation protein 1 homolog isoform X1
adenylate cyclase type 2-like, transcript variant X4
adenylate cyclase type 2-like, transcript variant X2
adenylate cyclase type 2-like, transcript variant X3
adenylate cyclase type 2-like, transcript variant X1
adenylate cyclase type 2-like, transcript variant X6
adenylate cyclase type 2-like, transcript variant X7
adenylate cyclase type 2-like, transcript variant X5
adenylate cyclase type 2-like, transcript variant X8
adenylate cyclase type 2-like, transcript variant X9
adenylate cyclase type 2-like isoform X3
adenylate cyclase type 2-like isoform X2
adenylate cyclase type 2-like isoform X1
adenylate cyclase type 2-like isoform X4
adenylate cyclase type 2-like, transcript variant X11
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
adenylate cyclase type 2-like, transcript variant X10
adenylate cyclase type 2-like, transcript variant X12
adenylate cyclase type 2-like, transcript variant X15
adenylate cyclase type 2-like, transcript variant X14
adenylate cyclase type 2-like, transcript variant X13
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
forkhead box C1-B, transcript variant X1
forkhead box C1-B, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
exonuclease mut-7 homolog, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 14 samples with support for all annotated introns
exonuclease mut-7 homolog, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 14 samples with support for all annotated introns
exonuclease mut-7 homolog, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 15 samples with support for all annotated introns
exonuclease mut-7 homolog, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 15 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 16 samples with support for all annotated introns
ribosomal RNA-processing protein 7 homolog A
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 16 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 124 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
protein singles bar, transcript variant X2
protein singles bar, transcript variant X1
pyridoxine/pyridoxamine 5'-phosphate oxidase, transcript variant X2
pyridoxine/pyridoxamine 5'-phosphate oxidase, transcript variant X1
pyridoxine/pyridoxamine 5'-phosphate oxidase, transcript variant X4
pyridoxine/pyridoxamine 5'-phosphate oxidase, transcript variant X3
pyridoxine/pyridoxamine 5'-phosphate oxidase isoform X2
pyridoxine/pyridoxamine 5'-phosphate oxidase isoform X1
pyridoxine/pyridoxamine 5'-phosphate oxidase isoform X4
pyridoxine/pyridoxamine 5'-phosphate oxidase isoform X3
atrial natriuretic peptide-converting enzyme, transcript variant X4
atrial natriuretic peptide-converting enzyme, transcript variant X1
atrial natriuretic peptide-converting enzyme, transcript variant X3
atrial natriuretic peptide-converting enzyme, transcript variant X2
atrial natriuretic peptide-converting enzyme isoform X2
atrial natriuretic peptide-converting enzyme isoform X1
armadillo segment polarity protein, transcript variant X4
armadillo segment polarity protein, transcript variant X1
armadillo segment polarity protein, transcript variant X2
armadillo segment polarity protein, transcript variant X3
armadillo segment polarity protein isoform X2
armadillo segment polarity protein isoform X1
armadillo segment polarity protein, transcript variant X6
armadillo segment polarity protein, transcript variant X5
armadillo segment polarity protein, transcript variant X7
armadillo segment polarity protein isoform X3
zinc finger protein 761, transcript variant X1
zinc finger protein 761, transcript variant X2
zinc finger protein 761, transcript variant X3
U11/U12 small nuclear ribonucleoprotein 48 kDa protein-like
astacin-like metalloprotease toxin 5, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
astacin-like metalloprotease toxin 5, transcript variant X2
high choriolytic enzyme 1-like isoform X1
astacin-like metalloprotease toxin 5 isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 18 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
pleckstrin homology domain-containing family A member 8, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 15 samples with support for all annotated introns
pleckstrin homology domain-containing family A member 8, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 18 samples with support for all annotated introns
pleckstrin homology domain-containing family A member 8 isoform X2
pleckstrin homology domain-containing family A member 8 isoform X1
putative zinc metalloproteinase YIL108W, transcript variant X1
putative zinc metalloproteinase YIL108W, transcript variant X2
putative zinc metalloproteinase YIL108W isoform X1
putative zinc metalloproteinase YIL108W isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
cytochrome P450 306a1, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 47 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 15 samples with support for all annotated introns
cytochrome P450 306a1, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 35 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
cytochrome P450 306a1, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 30 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
serine/threonine-protein kinase fused, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 14 samples with support for all annotated introns
serine/threonine-protein kinase fused, transcript variant X2
serine/threonine-protein kinase fused isoform X1
serine/threonine-protein kinase fused isoform X2
26S proteasome non-ATPase regulatory subunit 11
39S ribosomal protein L16, mitochondrial
uncharacterized LOC124432271, transcript variant X2
uncharacterized LOC124432271, transcript variant X1
uncharacterized protein LOC124432271 isoform X2
uncharacterized protein LOC124432271 isoform X1
phospholipase A2-like, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 16 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
phospholipase A2-like, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 16 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
phospholipase A2-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 23 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
phospholipase A2-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
ras-related protein M-Ras-like, transcript variant X1
ras-related protein M-Ras-like, transcript variant X3
ras-related protein M-Ras-like, transcript variant X2
116 kDa U5 small nuclear ribonucleoprotein component, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 17 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 13 samples with support for all annotated introns
116 kDa U5 small nuclear ribonucleoprotein component, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 17 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
116 kDa U5 small nuclear ribonucleoprotein component, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 17 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 12 samples with support for all annotated introns
116 kDa U5 small nuclear ribonucleoprotein component, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 17 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 10 samples with support for all annotated introns
116 kDa U5 small nuclear ribonucleoprotein component
polycomb group protein Psc-like, transcript variant X1
polycomb group protein Psc-like, transcript variant X5
polycomb group protein Psc-like, transcript variant X6
polycomb group protein Psc-like isoform X1
polycomb group protein Psc-like isoform X5
polycomb group protein Psc-like isoform X6
polycomb group protein Psc-like, transcript variant X2
polycomb group protein Psc-like, transcript variant X4
polycomb group protein Psc-like isoform X2
polycomb group protein Psc-like isoform X4
polycomb group protein Psc-like, transcript variant X3
polycomb group protein Psc-like isoform X3
uncharacterized LOC124432162, transcript variant X1
uncharacterized LOC124432162, transcript variant X3
uncharacterized LOC124432162, transcript variant X4
uncharacterized LOC124432162, transcript variant X2
uncharacterized protein LOC124432162 isoform X1
uncharacterized protein LOC124432162 isoform X3
uncharacterized protein LOC124432162 isoform X2
Y-box-binding protein 1, transcript variant X1
Y-box-binding protein 1, transcript variant X2
SET and MYND domain-containing protein 4
growth factor receptor-bound protein 14-like, transcript variant X6
growth factor receptor-bound protein 14-like, transcript variant X7
growth factor receptor-bound protein 14-like, transcript variant X5
growth factor receptor-bound protein 14-like, transcript variant X3
growth factor receptor-bound protein 14-like, transcript variant X4
growth factor receptor-bound protein 14-like, transcript variant X2
growth factor receptor-bound protein 14-like isoform X2
growth factor receptor-bound protein 14-like, transcript variant X1
growth factor receptor-bound protein 14-like isoform X1
growth factor receptor-bound protein 14-like isoform X3
growth factor receptor-bound protein 14-like, transcript variant X9
growth factor receptor-bound protein 14-like isoform X5
growth factor receptor-bound protein 14-like, transcript variant X10
growth factor receptor-bound protein 14-like, transcript variant X8
growth factor receptor-bound protein 14-like isoform X4
growth factor receptor-bound protein 14-like isoform X6
uncharacterized LOC124432257, transcript variant X2
uncharacterized LOC124432257, transcript variant X1
protein grindelwald, transcript variant X1
protein grindelwald, transcript variant X2
metabotropic glutamate receptor 3-like, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
metabotropic glutamate receptor 3-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 12 samples with support for all annotated introns
metabotropic glutamate receptor 3-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
metabotropic glutamate receptor 3-like isoform X2
metabotropic glutamate receptor 3-like isoform X1
sodium-coupled monocarboxylate transporter 2-like, transcript variant X1
sodium-coupled monocarboxylate transporter 2-like, transcript variant X2
sodium-coupled monocarboxylate transporter 2-like isoform X1
sodium-coupled monocarboxylate transporter 2-like isoform X2
CCR4-NOT transcription complex subunit 9
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 13 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 18 samples with support for all annotated introns
scavenger receptor class B member 1-like
NADH-ubiquinone oxidoreductase 49 kDa subunit-like, transcript variant X1
NADH-ubiquinone oxidoreductase 49 kDa subunit-like, transcript variant X2
NADH-ubiquinone oxidoreductase 49 kDa subunit-like isoform X2
NADH-ubiquinone oxidoreductase 49 kDa subunit-like isoform X1
NADH-ubiquinone oxidoreductase 49 kDa subunit-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 129 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
serine/threonine-protein kinase CBK1-like
broad-complex core protein isoforms 1/2/3/4/5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein
DNA-directed RNA polymerase II subunit RPB9
cleft lip and palate transmembrane protein 1 homolog
multidrug resistance-associated protein 1, transcript variant X2
multidrug resistance-associated protein 1, transcript variant X1
multidrug resistance-associated protein 1, transcript variant X3
multidrug resistance-associated protein 1, transcript variant X6
multidrug resistance-associated protein 1, transcript variant X5
multidrug resistance-associated protein 1, transcript variant X4
multidrug resistance-associated protein 1, transcript variant X8
multidrug resistance-associated protein 1, transcript variant X7
multidrug resistance-associated protein 1 isoform X8
multidrug resistance-associated protein 1 isoform X6
multidrug resistance-associated protein 1 isoform X5
multidrug resistance-associated protein 1 isoform X4
multidrug resistance-associated protein 1 isoform X2
multidrug resistance-associated protein 1 isoform X1
multidrug resistance-associated protein 1 isoform X3
multidrug resistance-associated protein 1 isoform X7
ral GTPase-activating protein subunit beta, transcript variant X5
ral GTPase-activating protein subunit beta, transcript variant X3
ral GTPase-activating protein subunit beta, transcript variant X4
ral GTPase-activating protein subunit beta, transcript variant X2
ral GTPase-activating protein subunit beta, transcript variant X1
ral GTPase-activating protein subunit beta isoform X5
ral GTPase-activating protein subunit beta isoform X3
ral GTPase-activating protein subunit beta isoform X4
ral GTPase-activating protein subunit beta isoform X2
ral GTPase-activating protein subunit beta isoform X1
transcription termination factor 2, transcript variant X2
transcription termination factor 2, transcript variant X1
transcription termination factor 2 isoform X2
transcription termination factor 2 isoform X1
Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
transfer RNA valine (anticodon UAC); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
insulin-like growth factor 2 mRNA-binding protein 2, transcript variant X2
insulin-like growth factor 2 mRNA-binding protein 2, transcript variant X1
insulin-like growth factor 2 mRNA-binding protein 2, transcript variant X4
insulin-like growth factor 2 mRNA-binding protein 2, transcript variant X3
insulin-like growth factor 2 mRNA-binding protein 2, transcript variant X7
insulin-like growth factor 2 mRNA-binding protein 2, transcript variant X6
insulin-like growth factor 2 mRNA-binding protein 2, transcript variant X5
insulin-like growth factor 2 mRNA-binding protein 2, transcript variant X9
insulin-like growth factor 2 mRNA-binding protein 2, transcript variant X8
insulin-like growth factor 2 mRNA-binding protein 2, transcript variant X10
insulin-like growth factor 2 mRNA-binding protein 2 isoform X7
insulin-like growth factor 2 mRNA-binding protein 2 isoform X6
insulin-like growth factor 2 mRNA-binding protein 2 isoform X4
insulin-like growth factor 2 mRNA-binding protein 2 isoform X3
insulin-like growth factor 2 mRNA-binding protein 1 isoform X2
insulin-like growth factor 2 mRNA-binding protein 2 isoform X1
insulin-like growth factor 2 mRNA-binding protein 1 isoform X9
insulin-like growth factor 2 mRNA-binding protein 1 isoform X8
insulin-like growth factor 2 mRNA-binding protein 1 isoform X5
insulin-like growth factor 2 mRNA-binding protein 1 isoform X10
uncharacterized LOC124432199, transcript variant X7
uncharacterized LOC124432199, transcript variant X6
uncharacterized LOC124432199, transcript variant X5
uncharacterized LOC124432199, transcript variant X3
uncharacterized LOC124432199, transcript variant X2
uncharacterized LOC124432199, transcript variant X1
uncharacterized LOC124432199, transcript variant X4
SPRY domain-containing SOCS box protein 3-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
SPRY domain-containing SOCS box protein 3-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 15 samples with support for all annotated introns
SPRY domain-containing SOCS box protein 3-like isoform X1
SPRY domain-containing SOCS box protein 3-like isoform X2
N-glycosylase/DNA lyase, transcript variant X1
N-glycosylase/DNA lyase, transcript variant X2
uncharacterized LOC124432195, transcript variant X1
uncharacterized LOC124432195, transcript variant X2
uncharacterized LOC124432195, transcript variant X3
uncharacterized LOC124432195, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 16 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 17 samples with support for all annotated introns
protein yippee-like 1, transcript variant X1
protein yippee-like 1, transcript variant X4
protein yippee-like 1, transcript variant X2
protein yippee-like 1, transcript variant X3
FGGY carbohydrate kinase domain-containing protein, transcript variant X2
FGGY carbohydrate kinase domain-containing protein, transcript variant X1
FGGY carbohydrate kinase domain-containing protein isoform X1
FGGY carbohydrate kinase domain-containing protein, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 12 samples with support for all annotated introns
FGGY carbohydrate kinase domain-containing protein isoform X2
serine/threonine-protein kinase pakE, transcript variant X3
serine/threonine-protein kinase pakE, transcript variant X2
serine/threonine-protein kinase pakE, transcript variant X4
serine/threonine-protein kinase pakE, transcript variant X1
serine/threonine-protein kinase pakE isoform X1
serine/threonine-protein kinase pakE isoform X3
serine/threonine-protein kinase pakE isoform X2
uncharacterized LOC124432231, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
uncharacterized LOC124432231, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
uncharacterized protein LOC124432231 isoform X2
uncharacterized protein LOC124432231 isoform X1
A-kinase anchor protein 10, mitochondrial, transcript variant X1
A-kinase anchor protein 10, mitochondrial isoform X1
A-kinase anchor protein 10, mitochondrial, transcript variant X2
A-kinase anchor protein 10, mitochondrial isoform X2
GTPase-activating protein, transcript variant X1
GTPase-activating protein, transcript variant X8
GTPase-activating protein, transcript variant X7
GTPase-activating protein, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
GTPase-activating protein, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
GTPase-activating protein, transcript variant X2
ras GTPase-activating protein 3 isoform X2
ras GTPase-activating protein 3 isoform X1
ras GTPase-activating protein 3 isoform X6
ras GTPase-activating protein 3 isoform X3
GTPase-activating protein, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 13 samples with support for all annotated introns
GTPase-activating protein, transcript variant X9
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 12 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 17 samples with support for all annotated introns
ras GTPase-activating protein 3 isoform X5
ras GTPase-activating protein 3 isoform X8
GTPase-activating protein, transcript variant X5
ras GTPase-activating protein 3 isoform X4
glutamic acid-rich protein, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 17 samples with support for all annotated introns
glutamic acid-rich protein, transcript variant X1
U2 snRNP-associated SURP motif-containing protein, transcript variant X2
U2 snRNP-associated SURP motif-containing protein, transcript variant X1
U2 snRNP-associated SURP motif-containing protein
E3 ubiquitin-protein ligase MSL2, transcript variant X3
E3 ubiquitin-protein ligase MSL2, transcript variant X1
E3 ubiquitin-protein ligase MSL2, transcript variant X2
E3 ubiquitin-protein ligase MSL2 isoform X1
E3 ubiquitin-protein ligase MSL2 isoform X2
E3 ubiquitin-protein ligase MSL2 isoform X3
NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 2
O-glucosyltransferase rumi homolog, transcript variant X2
O-glucosyltransferase rumi homolog, transcript variant X1
O-glucosyltransferase rumi homolog, transcript variant X3
O-glucosyltransferase rumi homolog isoform X1
O-glucosyltransferase rumi homolog isoform X2
matrix metalloproteinase-14, transcript variant X1
matrix metalloproteinase-14, transcript variant X3
matrix metalloproteinase-14, transcript variant X2
matrix metalloproteinase-14, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
kinesin-like protein KIF13B, transcript variant X6
kinesin-like protein KIF13B, transcript variant X1
kinesin-like protein KIF13B, transcript variant X2
kinesin-like protein KIF13B, transcript variant X3
kinesin-like protein KIF13B, transcript variant X4
kinesin-like protein KIF13B, transcript variant X7
kinesin-like protein KIF13B, transcript variant X5
adrenodoxin-like protein 2, mitochondrial
myb-like protein Q, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
myb-like protein Q, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 16 samples with support for all annotated introns
myb-like protein Q, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
myb-like protein Q, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 12 samples with support for all annotated introns
pyruvate kinase-like, transcript variant X1
pyruvate kinase-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 98% coverage of the annotated genomic feature by RNAseq alignments
uncharacterized LOC124432294, transcript variant X3
uncharacterized LOC124432294, transcript variant X1
uncharacterized LOC124432294, transcript variant X2
uncharacterized protein LOC124432294 isoform X3
uncharacterized protein LOC124432294 isoform X1
uncharacterized protein LOC124432294 isoform X2
frataxin homolog, mitochondrial, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 12 samples with support for all annotated introns
frataxin homolog, mitochondrial isoform X3
frataxin homolog, mitochondrial, transcript variant X2
frataxin homolog, mitochondrial, transcript variant X1
frataxin homolog, mitochondrial isoform X2
frataxin homolog, mitochondrial isoform X1
transcription initiation factor TFIID subunit 11
uncharacterized LOC124432299, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
uncharacterized LOC124432299, transcript variant X8
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
uncharacterized LOC124432299, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
uncharacterized LOC124432299, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns
uncharacterized LOC124432299, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 11 samples with support for all annotated introns
uncharacterized LOC124432299, transcript variant X7
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
uncharacterized LOC124432299, transcript variant X5
uncharacterized LOC124432299, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
uncharacterized protein LOC124432299 isoform X5
uncharacterized protein LOC124432299 isoform X4
uncharacterized protein LOC124432299 isoform X6
uncharacterized protein LOC124432299 isoform X1
uncharacterized protein LOC124432299 isoform X3
uncharacterized protein LOC124432299 isoform X2
uncharacterized protein LOC124432299 isoform X7
putative fatty acyl-CoA reductase CG5065, transcript variant X2
biogenesis of lysosome-related organelles complex 1 subunit 4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 17 samples with support for all annotated introns
putative fatty acyl-CoA reductase CG5065, transcript variant X3
putative fatty acyl-CoA reductase CG5065, transcript variant X1
putative fatty acyl-CoA reductase CG5065, transcript variant X5
putative fatty acyl-CoA reductase CG5065, transcript variant X4
putative fatty acyl-CoA reductase CG5065 isoform X1
putative fatty acyl-CoA reductase CG5065 isoform X3
putative fatty acyl-CoA reductase CG5065 isoform X2
guanine nucleotide-binding protein-like 1, transcript variant X2
guanine nucleotide-binding protein-like 1, transcript variant X1
guanine nucleotide-binding protein-like 1 isoform X1
guanine nucleotide-binding protein-like 1 isoform X2
SET and MYND domain-containing protein 4-like, transcript variant X1
SET and MYND domain-containing protein 4-like, transcript variant X2
SET and MYND domain-containing protein 4-like, transcript variant X3
SET and MYND domain-containing protein 4-like isoform X1
SET and MYND domain-containing protein 4-like isoform X2
furin-like protease 2, transcript variant X2
furin-like protease 2, transcript variant X3
furin-like protease 2, transcript variant X4
furin-like protease 2, transcript variant X1
furin-like protease 2, transcript variant X5
ubiquitin carboxyl-terminal hydrolase 3-like
serine/threonine-protein phosphatase 2A regulatory subunit B'' subunit gamma-like
zinc finger MYND domain-containing protein 10, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
zinc finger MYND domain-containing protein 10, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
zinc finger MYND domain-containing protein 10, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
zinc finger MYND domain-containing protein 10, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
zinc finger MYND domain-containing protein 10 isoform X1
zinc finger MYND domain-containing protein 10 isoform X2
40S ribosomal protein S12, transcript variant X1
40S ribosomal protein S12, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
RNA-binding protein 42, transcript variant X1
RNA-binding protein 42, transcript variant X2
radial spoke head 1 homolog, transcript variant X1
radial spoke head 1 homolog, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 14 samples with support for all annotated introns
uncharacterized LOC124432327, transcript variant X1
uncharacterized LOC124432327, transcript variant X2
uncharacterized LOC124432329, transcript variant X1
uncharacterized LOC124432329, transcript variant X2
uncharacterized protein LOC124432329 isoform X1
uncharacterized protein LOC124432329 isoform X2
etoposide-induced protein 2.4 homolog, transcript variant X1
etoposide-induced protein 2.4 homolog, transcript variant X2
etoposide-induced protein 2.4 homolog, transcript variant X3
etoposide-induced protein 2.4 homolog isoform X1
etoposide-induced protein 2.4 homolog isoform X2
transforming growth factor beta regulator 1, transcript variant X2
transforming growth factor beta regulator 1, transcript variant X1
transforming growth factor beta regulator 1 isoform X2
transforming growth factor beta regulator 1 isoform X1
CUGBP Elav-like family member 1, transcript variant X8
CUGBP Elav-like family member 1, transcript variant X31
CUGBP Elav-like family member 1, transcript variant X21
CUGBP Elav-like family member 1, transcript variant X12
CUGBP Elav-like family member 1, transcript variant X9
CUGBP Elav-like family member 1, transcript variant X4
CUGBP Elav-like family member 1, transcript variant X10
CUGBP Elav-like family member 1, transcript variant X3
CUGBP Elav-like family member 1, transcript variant X7
CUGBP Elav-like family member 1, transcript variant X6
CUGBP Elav-like family member 1, transcript variant X13
CUGBP Elav-like family member 1, transcript variant X15
CUGBP Elav-like family member 1, transcript variant X17
CUGBP Elav-like family member 1, transcript variant X1
CUGBP Elav-like family member 1, transcript variant X20
CUGBP Elav-like family member 1, transcript variant X22
CUGBP Elav-like family member 1, transcript variant X19
CUGBP Elav-like family member 1, transcript variant X18
CUGBP Elav-like family member 1, transcript variant X14
CUGBP Elav-like family member 1, transcript variant X11
CUGBP Elav-like family member 1, transcript variant X23
CUGBP Elav-like family member 1, transcript variant X25
CUGBP Elav-like family member 1, transcript variant X26
CUGBP Elav-like family member 1, transcript variant X16
CUGBP Elav-like family member 1, transcript variant X24
CUGBP Elav-like family member 1, transcript variant X27
CUGBP Elav-like family member 1, transcript variant X30
CUGBP Elav-like family member 1, transcript variant X29
CUGBP Elav-like family member 1, transcript variant X28
CUGBP Elav-like family member 1, transcript variant X5
CUGBP Elav-like family member 1, transcript variant X2
CUGBP Elav-like family member 2 isoform X12
CUGBP Elav-like family member 2 isoform X8
CUGBP Elav-like family member 2 isoform X4
CUGBP Elav-like family member 2 isoform X2
CUGBP Elav-like family member 1 isoform X10
CUGBP Elav-like family member 1 isoform X13
CUGBP Elav-like family member 1 isoform X6
CUGBP Elav-like family member 1 isoform X3
CUGBP Elav-like family member 1 isoform X11
CUGBP Elav-like family member 1 isoform X5
CUGBP Elav-like family member 1 isoform X7
CUGBP Elav-like family member 2 isoform X1
CUGBP Elav-like family member 1 isoform X14
CUGBP Elav-like family member 2 isoform X9
CUGBP Elav-like family member 2 isoform X15
CUGBP Elav-like family member 2 isoform X16
uncharacterized LOC124432332, transcript variant X2
uncharacterized LOC124432332, transcript variant X1
transfer RNA methionine (anticodon CAU); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
putative small proline-rich protein 5, transcript variant X2
putative small proline-rich protein 5, transcript variant X3
putative small proline-rich protein 5, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: cmsearch.
COORDINATES: nucleotide motif:Rfam:12.0:RF00003
cytoplasmic dynein 2 light intermediate chain 1, transcript variant X3
cytoplasmic dynein 2 light intermediate chain 1, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
cytoplasmic dynein 2 light intermediate chain 1, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
cytoplasmic dynein 2 light intermediate chain 1 isoform X2
cytoplasmic dynein 2 light intermediate chain 1 isoform X1
vacuolar protein sorting-associated protein 54
vacuolar protein sorting-associated protein 29, transcript variant X1
vacuolar protein sorting-associated protein 29, transcript variant X2
vacuolar protein sorting-associated protein 29, transcript variant X3
uncharacterized LOC124432266, transcript variant X2
uncharacterized LOC124432266, transcript variant X1
vacuolar protein sorting-associated protein 29
cell cycle checkpoint control protein RAD9A, transcript variant X4
cell cycle checkpoint control protein RAD9A, transcript variant X1
cell cycle checkpoint control protein RAD9A, transcript variant X3
cell cycle checkpoint control protein RAD9A, transcript variant X2
cell cycle checkpoint control protein RAD9A isoform X1
cell cycle checkpoint control protein RAD9A isoform X2
cell cycle checkpoint control protein RAD9A isoform X3
transfer RNA histidin (anticodon GUG); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
serine/threonine-protein kinase DCLK2, transcript variant X2
serine/threonine-protein kinase DCLK2, transcript variant X1
serine/threonine-protein kinase DCLK2, transcript variant X6
serine/threonine-protein kinase DCLK2, transcript variant X3
serine/threonine-protein kinase DCLK2, transcript variant X4
serine/threonine-protein kinase DCLK2, transcript variant X5
serine/threonine-protein kinase DCLK2, transcript variant X7
serine/threonine-protein kinase DCLK2 isoform X1
probable serine/threonine-protein kinase MARK-A isoform X2
serine/threonine-protein kinase DCLK2 isoform X3
probable cytosolic iron-sulfur protein assembly protein Ciao1, transcript variant X8
probable cytosolic iron-sulfur protein assembly protein Ciao1, transcript variant X5
probable cytosolic iron-sulfur protein assembly protein Ciao1, transcript variant X6
probable cytosolic iron-sulfur protein assembly protein Ciao1, transcript variant X7
probable cytosolic iron-sulfur protein assembly protein Ciao1, transcript variant X4
probable cytosolic iron-sulfur protein assembly protein Ciao1, transcript variant X3
probable cytosolic iron-sulfur protein assembly protein Ciao1, transcript variant X1
probable cytosolic iron-sulfur protein assembly protein Ciao1, transcript variant X2
probable cytosolic iron-sulfur protein assembly protein Ciao1 isoform X1
probable cytosolic iron-sulfur protein assembly protein Ciao1 isoform X2
probable cytosolic iron-sulfur protein assembly protein Ciao1 isoform X3
repressor of RNA polymerase III transcription MAF1 homolog, transcript variant X1
repressor of RNA polymerase III transcription MAF1 homolog, transcript variant X2
repressor of RNA polymerase III transcription MAF1 homolog
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: deleted 1 base in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: deleted 1 base in 1 codon; substituted 2 bases at 2 genomic stop codons; Derived by automated computational analysis using gene prediction method: Gnomon.
eukaryotic translation elongation factor 1 epsilon-1
kinesin-like protein KIF21A, transcript variant X1
kinesin-like protein KIF21A, transcript variant X2
kinesin-like protein KIF21A, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 14 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 16 samples with support for all annotated introns
bifunctional arginine demethylase and lysyl-hydroxylase PSR
histone-lysine N-methyltransferase, H3 lysine-79 specific, transcript variant X1
histone-lysine N-methyltransferase, H3 lysine-79 specific, transcript variant X2
histone-lysine N-methyltransferase, H3 lysine-79 specific, transcript variant X6
histone-lysine N-methyltransferase, H3 lysine-79 specific, transcript variant X4
histone-lysine N-methyltransferase, H3 lysine-79 specific, transcript variant X3
histone-lysine N-methyltransferase, H3 lysine-79 specific isoform X2
histone-lysine N-methyltransferase, H3 lysine-79 specific isoform X1
histone-lysine N-methyltransferase, H3 lysine-79 specific, transcript variant X5
histone-lysine N-methyltransferase, H3 lysine-79 specific isoform X3
A disintegrin and metalloproteinase with thrombospondin motifs 2-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 16 samples with support for all annotated introns
cilia- and flagella-associated protein 57
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
mediator of RNA polymerase II transcription subunit 20, transcript variant X1
mediator of RNA polymerase II transcription subunit 20, transcript variant X2
mediator of RNA polymerase II transcription subunit 20, transcript variant X3
mediator of RNA polymerase II transcription subunit 20 isoform X1
mediator of RNA polymerase II transcription subunit 20 isoform X2
mediator of RNA polymerase II transcription subunit 20 isoform X3
facilitated trehalose transporter Tret1-2 homolog, transcript variant X6
facilitated trehalose transporter Tret1-2 homolog, transcript variant X1
facilitated trehalose transporter Tret1-2 homolog, transcript variant X3
facilitated trehalose transporter Tret1-2 homolog, transcript variant X4
facilitated trehalose transporter Tret1-2 homolog, transcript variant X2
facilitated trehalose transporter Tret1-2 homolog, transcript variant X8
facilitated trehalose transporter Tret1-2 homolog isoform X1
facilitated trehalose transporter Tret1-2 homolog, transcript variant X5
facilitated trehalose transporter Tret1-2 homolog isoform X2
facilitated trehalose transporter Tret1-2 homolog, transcript variant X7
facilitated trehalose transporter Tret1-2 homolog, transcript variant X10
facilitated trehalose transporter Tret1-like isoform X3
facilitated trehalose transporter Tret1-2 homolog, transcript variant X9
facilitated trehalose transporter Tret1-like isoform X4
facilitated trehalose transporter Tret1-2 homolog isoform X5
dystroglycan 1-like, transcript variant X2
dystroglycan 1-like, transcript variant X1
dystroglycan 1-like, transcript variant X3
dystroglycan 1-like, transcript variant X4
dystroglycan 1-like, transcript variant X5
uncharacterized protein LOC124432246 isoform X1
uncharacterized protein LOC124432246 isoform X2
carbonic anhydrase 2, transcript variant X1
carbonic anhydrase 2, transcript variant X3
carbonic anhydrase 2, transcript variant X2
uncharacterized LOC124432248, transcript variant X2
uncharacterized LOC124432248, transcript variant X1
uncharacterized protein LOC124432248 isoform X2
uncharacterized protein LOC124432248 isoform X1
vacuolar protein sorting-associated protein 53 homolog, transcript variant X1
vacuolar protein sorting-associated protein 53 homolog, transcript variant X2
vacuolar protein sorting-associated protein 53 homolog